UNIVERSITE PARIS DESCARTES;UNIVERSITÉ PARIS-SUD 11;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;UNIVERSITE PARIS DIDEROT;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
Maria MITEVA,Bruno VILLOUTREIX,David J. AITKEN,Anne-Françoise BURNOL,Anais GONDOIN,Tarik ISSAD
申请号：
US16496111
公开号：
US20200030297A1
申请日:
2018.03.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to a compound inhibiting the interaction between a Grb14 protein and an insulin receptor of Formula (I) or Formula (II),their salts, solvates, and/or diastereoisomers, for use for therapeutic purposes, in particular for the treatment of insulin resistance, and to pharmaceutical compositions containing such compounds.
